Lauren S. Schlesselman, PharmD
CASEONE:
While on rotation at an outpatient
cardiology clinic, a pharmacy
student is assigned to
visit patients with a medical
student and a resident. The first
appointment of the day is with
QT, an 80-year-old woman who
is accompanied by her son.The
son mentions that QT is not
feeling well—"probably one of those bugs that are going
around"—but they did not want to miss this appointment. The
son explains that his mother's symptoms include headache, diarrhea,
vomiting, abdominal pain, weakness, and confusion. This
morning, she was complaining of blurred vision, flashes of light,
and halos around objects. Since she has been a little confused,
the son was not sure whether or not to believe her.
On physical examination, QT's vital signs are: blood pressure
145/95 mm Hg, heart rate 40, respiratory rate 20, and temperature
99°F. QT does not have any significant orthostatic blood
pressure changes. The resident notes mild edema. QT also has
faintly audible rales and rhonchi. While waiting for results from
the blood work, the resident performs an electrocardiogram,
which shows second-degree atrioventricular (AV) block.
While the resident is performing the examination, the pharmacy
student reviews QT's medical records. According to the
chart, she is currently taking:
- Furosemide, 20 mg po qd
- Omeprazole, 20 mg po qd
- Alendronate, 70 mg po q week
- Captopril, 25 mg po bid
- Ranitidine, 150 mg po bid
- Digoxin, 0.25 mg po qd
- Naproxen, 250 mg po bid
Attempting to act knowledgeable, the medical student
informs the son that QT's symptoms are related to a viral infection
that should resolve in a few days. Discretely, the pharmacy
student informs the medical student that he believes her symptoms
are actually related to one of her medications.
Which medication does the pharmacy student suspect is
causing these symptoms?
CASE TWO:
At the beginning of her shift,
a nurse is listening to the medical
team discuss her patient in
the Intensive Care Unit (ICU).
When the doctor asks the
nurse if she has received the
results of the morning blood
work, the nurse replies that she
has not because she was running
late, lifting her purse as evidence that she has not yet gotten
herself situated. She suddenly collapses, sending the contents
of her purse all over the floor. While the medical student
signals for a "Code Blue," the remainder of the team attempts
to revive the nurse.
Despite her unresponsive state, the nurse is breathing spontaneously
and has a pulse with a normal rate and rhythm.
Another nurse, while attempting to establish intravenous
access, comments that the unresponsive nurse is drenched in
sweat. A portable cardiac monitor shows the nurse remains in
normal sinus rhythm.
The attending physician asks if any of the ICU personnel
know anything about the unresponsive nurse's medical history.
One of the other nurses, says that numerous prescription
bottles fell out of the purse. The recently filled bottles
contained metformin, aspirin, propranolol, loratadine, and
vials of regular and Neutral Protamine Hagedorn insulin.
The attending physician recommends they check the
unresponsive nurse's blood sugar. The glucometer shows
her blood sugar is <40 mg/dL. The medical team is surprised
that a nurse would not have noticed the signs of hypoglycemia.
Which medication does the attending physician suspect
caused the nurse's unawareness of her hypoglycemia?
Dr. Schlesselman is an assistant clinical professor at the University of Connecticut School of
Pharmacy.
| Click Here For The Answer -----------> |
[-] |
CASE ONE: QT is demonstrating classic symptoms of digoxin toxicity, including cardiac, ocular,
gastrointestinal, and central nervous
system manifestations. The most dangerous manifestations are cardiac due to the risk of arrhythmia,
particularly AV conduction disturbances. Risk factors
for developing digoxin toxicity include pharmacodynamic changes in the elderly, concurrent medications,
and severity of heart failure.
CASE TWO: The attending physician suspects propranolol, a nonselective beta-adrenergic blocker,
caused the nurse to be unaware of her hypoglycemia.
During beta-blockade, symptoms mediated by the sympathetic nervous system, including tachycardia,
palpitations, and tremors, are blocked.
Cholinergically mediated symptoms, such as diaphoresis, are not blocked. Nonselective beta-adrenergic
blockers may also potentiate insulin-induced
hypoglycemia and delay blood glucose recovery following a hypoglycemic event.